Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia-Reference-Cited by-同舟云学术

Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia

Published:2008-03-12 Issue:4 Volume:89 Page:868-873
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Giardini C.,Galimbbrti M.,Lucarelli G.,Polchi P.,Angelucci E.,Baronciani D.,Gaziev D.,Erer B.,Nasa G. La,Barbanti I.,Muretto P.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1995.tb08426.x/fullpdf

Reference18 articles.

1. The pathology of hepatic iron overload: a free radical-mediated process;Bacon;Hepatology,1990

2. Value of hepatic iron measurements in early hemochtomatosis and determination of the critical iron level associated with fibrosis;Basset;Hepatology,1986

3. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis;Clemente;C. Journal of Pediatrics,1994

4. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients;Virgiliis;American Journal of Pediatric Hematology-Oncology,1983

5. Body iron excretion in man: a collaborative study;Green;American Journal of Medicine,1968

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation for sickle cell disease: updates and future directions;Hematology;2021-12-10

2. Outcome of iron reduction therapy in ex-thalassemics;PLOS ONE;2021-01-22

3. Hematopoietic Cell Transplantation for Sickle Cell Disease;Frontiers in Pediatrics;2021-01-05

4. Évaluation et prise en charge de la surcharge en fer post-greffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2016-11

5. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation;Pediatric Blood & Cancer;2016-08-31